Answers are grounded in this paper and cite their sources.
Accurate and well maintained patient-level data is needed to gather and formulate real-world evidence that is necessary to optimize existing treatment and shape future treatment for patients with hematological malignancies.
No takes yet. Share an insight, caveat, or question.
Julie Vose (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: